Market Tracker

03/22 5:16pm ET

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

10.75
Delayed Data
As of 3:59pm ET
 +0.10 / +0.94%
Today’s Change
9.62
Today|||52-Week Range
17.55
-20.66%
Year-to-Date
Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert
Mar 14 / Zacks.com - Paid Partner Content
Here's Why Sucampo Pharmaceuticals Rose as Much as 13.3% Today
Mar 08 / MotleyFool.com - Paid Partner Content
Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed
Mar 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close10.65
Today’s open10.60
Day’s range10.50 - 10.80
Volume496,688
Average volume (3 months)1,089,178
Market cap$494.8M
Dividend yield--
Data as of 3:59pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)-42.47%
Earnings growth (this year)-6.58%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+50.19%
P/E ratio25.6
Price/Sales2.58
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...+0.20+0.92%
OMEROmeros Corp+0.16+1.44%
SCLNSciClone Pharmaceuti...+0.10+1.06%
CYTKCytokinetics Inc+0.60+4.92%
Data as of 3:59pm ET, 03/22/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.31
Annual revenue (last year)$230.1M
Annual profit (last year)$18.5M
Net profit margin8.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts